+

WO2013105997A3 - Compositions et procédés de remplacement de tissu mou améliorés - Google Patents

Compositions et procédés de remplacement de tissu mou améliorés Download PDF

Info

Publication number
WO2013105997A3
WO2013105997A3 PCT/US2012/025400 US2012025400W WO2013105997A3 WO 2013105997 A3 WO2013105997 A3 WO 2013105997A3 US 2012025400 W US2012025400 W US 2012025400W WO 2013105997 A3 WO2013105997 A3 WO 2013105997A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft tissue
compositions
tissue replacement
replacement methods
improved soft
Prior art date
Application number
PCT/US2012/025400
Other languages
English (en)
Other versions
WO2013105997A2 (fr
Inventor
Dennis E. Van Epps
Guang-Liang Jiang
Adam L. Collette
Rebecca L. Horan
Jing-song CHEN
Gregory H. Altman
Wha-Bin Im
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/193,744 external-priority patent/US8697056B2/en
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Priority to EP12708197.4A priority Critical patent/EP2678022A2/fr
Publication of WO2013105997A2 publication Critical patent/WO2013105997A2/fr
Publication of WO2013105997A3 publication Critical patent/WO2013105997A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne des compositions et des procédés permettant de traiter un défaut de tissu mou chez un individu.
PCT/US2012/025400 2011-02-23 2012-02-16 Compositions et procédés de remplacement de tissu mou améliorés WO2013105997A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12708197.4A EP2678022A2 (fr) 2011-02-23 2012-02-16 Compositions et procédés de remplacement de tissu mou améliorés

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161445928P 2011-02-23 2011-02-23
US61/445,928 2011-02-23
US13/193,744 US8697056B2 (en) 2010-08-19 2011-07-29 Compositions and soft tissue replacement methods
US13/193,744 2011-07-29

Publications (2)

Publication Number Publication Date
WO2013105997A2 WO2013105997A2 (fr) 2013-07-18
WO2013105997A3 true WO2013105997A3 (fr) 2014-01-09

Family

ID=48782054

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/025400 WO2013105997A2 (fr) 2011-02-23 2012-02-16 Compositions et procédés de remplacement de tissu mou améliorés

Country Status (2)

Country Link
EP (1) EP2678022A2 (fr)
WO (1) WO2013105997A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060069018A1 (en) * 2002-10-10 2006-03-30 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
US20110008406A1 (en) * 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110009960A1 (en) * 2001-11-16 2011-01-13 Allergan, Inc. Prosthetic fabric structure
WO2012024072A1 (fr) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions à base de tissu adipeux et d'un analogue de la pge2 et leur utilisation dans le traitement d'une affection d'un tissu mou

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756911A (en) 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6110590A (en) 1998-04-15 2000-08-29 The University Of Akron Synthetically spun silk nanofibers and a process for making the same
TWI249520B (en) 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
US20080299213A2 (en) 1999-11-05 2008-12-04 Donald Kleinsek Augmentation and repair of spincter defects with cells including adipocytic cells
AU2001261465A1 (en) 2000-05-12 2001-11-26 The Regents Of The University Of Michigan Reverse fabrication of porous materials
US6423252B1 (en) 2000-06-23 2002-07-23 Ethicon, Inc. Methods of making micropatterned foams
JP3984164B2 (ja) 2000-11-27 2007-10-03 ファイザー・プロダクツ・インク 骨粗鬆症治療用ｅｐ４受容体選択的アゴニスト
KR100826866B1 (ko) 2001-07-23 2008-05-06 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하질환의 치료제
US6902932B2 (en) 2001-11-16 2005-06-07 Tissue Regeneration, Inc. Helically organized silk fibroin fiber bundles for matrices in tissue engineering
US20040254230A1 (en) 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
AU2003249366A1 (en) 2002-06-24 2004-01-06 Tufts University Silk biomaterials and methods of use thereof
AU2003253690A1 (en) 2002-06-24 2004-01-06 Massachusetts Institute Of Technology Silk biomaterials and methods of use thereof
US7842780B2 (en) 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
WO2005012606A2 (fr) 2003-04-10 2005-02-10 Tufts University Solution aqueuse concentree de fibroine et utilisation
US7972628B2 (en) 2003-10-01 2011-07-05 University Of Washington Porous biomaterials
BRPI0506983A (pt) 2004-01-20 2007-07-03 Allergan Inc composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
JPWO2006016695A1 (ja) 2004-08-10 2008-05-01 小野薬品工業株式会社 Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤
WO2006137472A1 (fr) 2005-06-24 2006-12-28 Taisho Pharmaceutical Co., Ltd. Dérivé de la prostaglandine
WO2007016545A2 (fr) 2005-08-01 2007-02-08 The Regents Of The University Of Michigan Materiaux poreux presentant des geometries de tailles multiples
FR2896511B1 (fr) 2006-01-26 2012-10-26 Centre Nat Rech Scient Procede de culture de cellules issues du tissu adipeux et leurs applications.
WO2008092861A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques utilisés comme agonistes de ep4
WO2008092860A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques comme agonistes de ep4
WO2008092862A1 (fr) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Dérivés bicycliques utilisés comme agonistes de ep4
WO2008103807A2 (fr) 2007-02-21 2008-08-28 Cedars-Sinai Medical Center Méthodes de production de préadipocytes et d'augmentation de la prolifération de cellules souches/progénitrices adipeuses adultes
JP5479092B2 (ja) 2007-05-08 2014-04-23 国立大学法人浜松医科大学 Ｅｐ４アゴニストを含有してなる細胞傷害性ｔ細胞の活性化剤
GB0810615D0 (en) 2008-06-10 2008-07-16 Glaxo Group Ltd Novel pharmaceutical

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009960A1 (en) * 2001-11-16 2011-01-13 Allergan, Inc. Prosthetic fabric structure
US20060069018A1 (en) * 2002-10-10 2006-03-30 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
US20110008406A1 (en) * 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
WO2012024072A1 (fr) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions à base de tissu adipeux et d'un analogue de la pge2 et leur utilisation dans le traitement d'une affection d'un tissu mou

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALTMAN A M ET AL: "Adhesion, migration and mechanics of human adipose-tissue-derived stem cells on silk fibroinchitosan matrix", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 4, 1 April 2010 (2010-04-01), pages 1388 - 1397, XP026921459, ISSN: 1742-7061, [retrieved on 20091025], DOI: 10.1016/J.ACTBIO.2009.10.034 *

Also Published As

Publication number Publication date
WO2013105997A2 (fr) 2013-07-18
EP2678022A2 (fr) 2014-01-01

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
EP3285688A4 (fr) Implants cornéens
EP2531138A4 (fr) Implants intraoculaires, et kits et procédés associés
WO2012149472A9 (fr) Procédés, compositions et trousses pour traiter et prévenir des états neurologiques
EP2739237A4 (fr) Instrument chirurgical et son procédé de commande
EP2757999A4 (fr) Implant de tissu dur
PT2689743T (pt) Broca para cirurgia de implantes
EP2771397A4 (fr) Composition de caoutchouc chargée de silice et son procédé de fabrication
GB201305198D0 (en) Kits, components and methods for tissue reconstruction
BR112014004192A2 (pt) composição de tratamento de sementes, e, método de tratamento de sementes
HK1201213A1 (en) Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
PL2701637T3 (pl) Implant kręgosłupowy, narzędzie do tego i sposób dystrakcji implantu kręgosłupowego
PL2681280T3 (pl) Biomateriał, sposób wytwarzania biomateriału i jego zastosowanie
EP2771398A4 (fr) Composition de caoutchouc chargée avec de la silice et son procédé de préparation
EP2903537A4 (fr) Suture pour réparation de tissu mou
WO2012097272A8 (fr) Compositions d'hydrogel stable incluant des additifs
GB2505800B (en) Valve body arrangement and method for manufacture thereof as well as valve having the valve body arrangement
WO2012149334A3 (fr) Procédés et compositions pour préparer et utiliser des anticorps spécifiques à une conformation
EP3016516A4 (fr) Greffon formé de tissus mous
EP2732068B8 (fr) Procédé pour améliorer la résistance à l'usure d'instruments chirurgicaux colorés
WO2013038269A3 (fr) Appareil et procédés permettant de traiter des morceaux de tiges de canne à sucre
WO2012112757A3 (fr) Compositions et procédés améliorés de remplacement de tissu mou
EP2563120A4 (fr) Méthodes, compositions et kits de traitement thérapeutique
EP3236883A4 (fr) Prothèse implantable pour la réparation de tissus mous

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12708197

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2012708197

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012708197

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载